Can you recommend any literature on the differences between pharmacological inhibition and the knockout model, in terms of advantages and disadvantages? Thank you in advance.
1. El-Brolosy, M. A., & Stainier, D. Y. (2017). Genetic compensation: A phenomenon in search of mechanisms. PLoS Genetics, 13(7), e1006780. [https://doi.org/10.1371/journal.pgen.1006780] → Explores how gene knockouts can lead to transcriptional adaptation that doesn’t occur with pharmacological inhibition.
2. Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011). The resurgence of covalent drugs. Nature Reviews Drug Discovery, 10(4), 307–317. [https://doi.org/10.1038/nrd3410] → While focused on covalent drugs, it provides context on pharmacological specificity and off-target effects.
Pharmacological inhibition and genetic knockout models each have distinct advantages and limitations, and recent studies have illuminated critical differences between them. Pharmacological inhibition allows for reversible, dose-dependent, and often temporally controlled perturbations, which more closely mimic therapeutic scenarios, but it may suffer from off-target effects and incomplete inhibition, leaving residual protein function that can still mediate interactions. In contrast, knockout models ensure complete ablation of gene function, allowing for robust mechanistic insights, but they often trigger compensatory pathways—such as transcriptional adaptation or upregulation of redundant genes—not seen with pharmacological inhibition, leading to phenotype discrepancies. For example, El-Brolosy & Stainier (2017) highlight genetic compensation following knockouts that may mask phenotypes seen in inhibitor-treated models (PLoS Genet. 13(7): e1006780), while Minikel et al. (2020) demonstrate the utility of human loss-of-function data to predict drug target tolerability (Nature 581, 459–464). Additionally, Krill‑Burger et al. (2023) show that partial suppression uncovers vulnerabilities missed by complete knockouts (Genome Biol 24, 192).
Literature in support:
Article Evaluating drug targets through human loss-of-function genet...
Article Genetic compensation: A phenomenon in search of mechanisms